Philips and Marin General Hospital Announce USD 90 Million, 15-Year Strategic Partnership to Transform Patient Care

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) and Marin General Hospital ("MGH") today announced a 15-year, USD 90 million strategic partnership to transform and improve health care for thousands of patients across Marin County, just north of San Francisco. This is the first large scale partnership of its kind for an independent community hospital and the third for Philips in North America in the last six months. This latest strategic partnership signals a growing trend within hospitals and health systems to better manage the cost and complexity of their technology investments, while expanding quality access to advanced medical care to improve patient outcomes.

Through this strategic partnership, which is based on an enterprise managed services model, Philips will provide MGH with a comprehensive range of advanced medical technologies including imaging systems, patient monitoring, telehealth and clinical informatics solutions as well as clinical education, consulting and design services.

MGH is an award-winning independent hospital, renowned for being in the top five percent of hospitals in the United States, noted with a Healthgrades Distinguished Hospital award for excellence in clinical care for two years running. As part of the hospital's strategy to provide the most advanced care possible for the local community, it plans to break ground in 2016 on a hospital replacement project, and open a state-of-the-art breast health center. In addition to treating patients with the latest advanced treatments and technology, Marin General Hospital integrates complementary holistic care and support services through the its Center for Integrative Health & Wellness into treatment plans.

"We want to help keep residents of Marin healthy, and that means providing quality care close to home, including a new building, state-of-the-art health care technologies and services that will allow us to deliver on our goal of treating the whole patient - mind, body and spirit," said Marin General Hospital's Chief Information & Technology Integration Officer Mark Zielazinski. "As an independent community hospital, we have made a conscious decision to partner with Philips, an industry leader, who can support us in taking a long-term view and quickly adopting the latest digital health technologies, while creating an exceptional experience for our patients."

The strategic partnership underscores Philips’ commitment to provide new solutions for hospitals and health systems driven by a fundamental shift in U.S. health care management towards strategic partnerships for creating long-term patient value while managing costs, complexity, and risk. In the initial phase of a similar, long-term partnership with Philips, a hospital reported a 35 percent reduction in technology spending, while improving clinical quality.

"Forward thinking organizations such as Marin General Hospital understand that for community hospitals to differentiate themselves and to comply with new value based models, they need to focus on the patient experience and team up with a technology partner that has a deep understanding of how a hospital operates," said Frans van Houten, CEO of Royal Philips. "By partnering with Philips, Marin General Hospital not only has access to over a century of experience in leading healthcare technology, solutions and services, they have a partner with the right resources and skill set to help them deliver an excellent patient experience, high quality health care and manage costs. This allows them to focus on what matters most: delivering better care to the people in their communities."

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 106,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

About Marin General Hospital
Marin General Hospital has been meeting the community's health care needs since 1952. Many Marin County residents choose to live here because they appreciate the healthy lifestyle and transformative natural environment. In keeping with the values and needs of the community, Marin General Hospital is dedicated to treating the whole patient, mind, body and soul. Their mission is to provide the people of Marin with the healing care they want and deserve.

Marin General Hospital offers advanced medical expertise, technology, and treatments in an exceptionally healing environment. It also gives patients the opportunity to complement their medical treatment with integrative therapies at our Center for Integrative Health & Wellness. Together, Marin General Hospital care teams deliver award-winning services that are recognized by patients and their families, as well as by independent organizations who rank the hospital among the best.

Most Popular Now

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Emotional Cognition Analysis Enables Nea…

A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain...

New Recommendations to Increase Transpar…

Patients will be better able to benefit from innovations in medical artificial intelligence (AI) if a new set of internationally-agreed recommendations are followed. A new set of recommendations published in The...

Digital Health Unveils Draft Programme f…

18 - 19 March 2025, Birmingham, UK. Digital Health has unveiled the draft programme for its Rewired 2025 event which will take place at the NEC in Birmingham in March next...

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Leveraging AI to Assist Clinicians with …

Physical examinations are important diagnostic tools that can reveal critical insights into a patient's health, but complex conditions may be overlooked if a clinician lacks specialized training in that area...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...